TNF and inflammatory bowel disease: We found that infliximab, a chimeric monoclonal antibody and a biological drug that works against TNF-α and is widely used to treat autoimmune diseases, such as inflammatory bowel disease and multiple sclerosis42,43, efficiently blocks the necroptosis of EC in vitro and in vivo.